• 15614 Citations
  • 52 Scopus h-Index
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2019

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer (British Journal of Cancer, (2019), 120, 2, (183-189), 10.1038/s41416-018-0343-z)

Gorbunova, V., Beck, J. T., Hofheinz, R. D., Garcia-Alfonso, P., Nechaeva, M., Gracian, A. C., Mangel, L., Fernandez, E. E., Deming, D. A., Ramanathan, R. K., Torres, A. H., Sullivan, D., Luo, Y. & Berlin, J. D., Aug 27 2019, In : British journal of cancer. 121, 5, p. 429-430 2 p.

Research output: Contribution to journalComment/debate

Open Access
2018

Erratum: Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours (British journal of cancer (2018) 118 2 (153-161))

Infante, J. R., Korn, R. L., Rosen, L. S., LoRusso, P., Dychter, S. S., Zhu, J., Maneval, D. C., Jiang, P., Shepard, H. M., Frost, G., Von Hoff, D. D., Borad, M. J. & Ramanathan, R. K., Jan 1 2018, In : British journal of cancer. 118, 2, p. e3

Research output: Contribution to journalComment/debate

Open Access
2013

Current and emerging treatment options in pancreatic cancer

Ramanathan, R. K. & Piper, V. G., Aug 1 2013, In : Clinical Advances in Hematology and Oncology. 11, 8, p. 523-525 3 p.

Research output: Contribution to journalComment/debate

2011

Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

Bao, P. Q., Ramanathan, R. K., Krasinkas, A., Bahary, N., Lembersky, B. C., Bartlett, D. L., Hughes, S. J., Lee, K. K., James Moser, A. & Zeh, H. J., Dec 1 2011, In : Annals of surgical oncology. 18, SUPPL. 3, p. S323

Research output: Contribution to journalComment/debate

2010

What's Causing This Woman's Chest Pain?

Iyengar, T., Ramanathan, R. K. & Gold, P. J., Jan 2010, In : Gastroenterology. 138, 1, p. e1-e2

Research output: Contribution to journalComment/debate

2007

Erratum: Article on pharmacokinetic study of vorinostat (Clinical Cancer Research (2007) 13, (3605-3610))

Ramalingam, S. S., Parise, R. A. & Ramanathan, R. K., Oct 15 2007, In : Clinical Cancer Research. 13, 20, 1 p.

Research output: Contribution to journalComment/debate

2006

Erratum: A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer (Annals of Oncology (2005) vol. 16 (1639-1645)

Oettle, H., Richards, D., Ramanathan, R. K., van Laethem, J. L., Peeters, M., Fuchs, M., Zimmermann, A., John, W., Von Hoff, D., Arning, M., Kindler, H. L., Chen, J. S. & Chao, Y., Mar 2006, In : Annals of Oncology. 17, 3, 1 p.

Research output: Contribution to journalComment/debate

2005

Erratum: A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma (American Journal of Clinical Oncology (December 2004) 27, 6 (505-509))

Eng, C., Ramanathan, R. K., Wong, M. K., Remick, S. C., Dai, L., Wade-Oliver, K. T., Mani, S. & Kindler, H. L., Oct 1 2005, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 28, 5, 1 p.

Research output: Contribution to journalComment/debate